Literature DB >> 15475422

Overdiagnosis in early detection programs.

Ori Davidov1, Marvin Zelen.   

Abstract

Overdiagnosis refers to the situation where a screening exam detects a disease that would have otherwise been undetected in a person's lifetime. The disease would have not have been diagnosed because the individual would have died of other causes prior to its clinical onset. Although the probability of overdiagnosis is an important quantity for understanding early detection programs it has not been rigorously studied. We analyze an idealized early detection program and derive the mathematical expression for the probability of overdiagnosis. The results are studied numerically for prostate cancer and applied to a variety of screening schedules. Our investigation indicates that the probability of overdiagnosis is remarkably high.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15475422     DOI: 10.1093/biostatistics/kxh012

Source DB:  PubMed          Journal:  Biostatistics        ISSN: 1465-4644            Impact factor:   5.899


  12 in total

Review 1.  Influence of study features and methods on overdiagnosis estimates in breast and prostate cancer screening.

Authors:  Ruth Etzioni; Roman Gulati; Leslie Mallinger; Jeanne Mandelblatt
Journal:  Ann Intern Med       Date:  2013-06-04       Impact factor: 25.391

2.  A limited Review of Over Diagnosis Methods and Long Term Effects in Breast Cancer Screening.

Authors:  Dongfeng Wu; Adriana Pérez
Journal:  Oncol Rev       Date:  2011-09-01

Review 3.  Overdiagnosis and overtreatment of prostate cancer.

Authors:  Stacy Loeb; Marc A Bjurlin; Joseph Nicholson; Teuvo L Tammela; David F Penson; H Ballentine Carter; Peter Carroll; Ruth Etzioni
Journal:  Eur Urol       Date:  2014-01-09       Impact factor: 20.096

Review 4.  Missteps in Current Estimates of Cancer Overdiagnosis.

Authors:  Christoph I Lee; Ruth Etzioni
Journal:  Acad Radiol       Date:  2016-11-25       Impact factor: 3.173

5.  Identification of the Fraction of Indolent Tumors and Associated Overdiagnosis in Breast Cancer Screening Trials.

Authors:  Marc D Ryser; Roman Gulati; Marisa C Eisenberg; Yu Shen; E Shelley Hwang; Ruth B Etzioni
Journal:  Am J Epidemiol       Date:  2019-01-01       Impact factor: 4.897

6.  Empirical estimates of the lead time distribution for prostate cancer based on two independent representative cohorts of men not subject to prostate-specific antigen screening.

Authors:  Caroline J Savage; Hans Lilja; Angel M Cronin; David Ulmert; Andrew J Vickers
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-04-20       Impact factor: 4.254

7.  Breast cancer incidence and overdiagnosis in Catalonia (Spain).

Authors:  Montserrat Martinez-Alonso; Ester Vilaprinyo; Rafael Marcos-Gragera; Montserrat Rue
Journal:  Breast Cancer Res       Date:  2010-08-03       Impact factor: 6.466

8.  Stage-specific cancer incidence: an artificially mixed multinomial logit model.

Authors:  Solomon Chefo; Alex Tsodikov
Journal:  Stat Med       Date:  2009-07-10       Impact factor: 2.373

Review 9.  Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.

Authors:  Ruth Etzioni; Roman Gulati
Journal:  J Natl Cancer Inst       Date:  2015-11-18       Impact factor: 13.506

Review 10.  Quantifying and monitoring overdiagnosis in cancer screening: a systematic review of methods.

Authors:  Jamie L Carter; Russell J Coletti; Russell P Harris
Journal:  BMJ       Date:  2015-01-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.